Your Health. Your Family. Your Choice.
Administered by: Unknown Purchased by: ?
Life Threatening? No
Write-up: This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Apr-2021 and was forwarded to Moderna on 02-Apr-2021. This regulatory authority case was reported by an other and describes the occurrence of BLOOD GLUCOSE INCREASED and CEREBRAL THROMBOSIS in a 76-year-old female patient who received mRNA-1273 (COVID 19 Vaccine Moderna) for COVID-19 vaccination. The patient''s past medical history included Diabetes, Ehlers-Danlos syndrome and Hypertension. In February 2021, the patient received first dose of mRNA-1273 (COVID 19 Vaccine Moderna) (unknown route) 1 dosage form. In February 2021, the patient experienced BLOOD GLUCOSE INCREASED (seriousness criterion death) and CEREBRAL THROMBOSIS (seriousness criterion death). The cause of death was not reported. It is unknown if an autopsy was performed. The action taken with mRNA-1273 (COVID 19 Vaccine Moderna) (Unknown Route) was unknown. Treatment information was not provided. Concomitant medications were not reported. Very limited information regarding these events has been provided at this time. The events are probably related to the patient''s comorbidities. Reporter did not allow further contact; Sender''s Comments: Very limited information regarding these events has been provided at this time. The events are probably related to the patient''s comorbidities; Reported Cause(s) of Death: Unknown cause of death
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166